1. Home
  2. CUTR vs VIRX Comparison

CUTR vs VIRX Comparison

Compare CUTR & VIRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CUTR
  • VIRX
  • Stock Information
  • Founded
  • CUTR 1988
  • VIRX 2007
  • Country
  • CUTR United States
  • VIRX United States
  • Employees
  • CUTR N/A
  • VIRX N/A
  • Industry
  • CUTR Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • VIRX Biotechnology: Pharmaceutical Preparations
  • Sector
  • CUTR Health Care
  • VIRX Health Care
  • Exchange
  • CUTR Nasdaq
  • VIRX Nasdaq
  • Market Cap
  • CUTR 13.9M
  • VIRX 8.8M
  • IPO Year
  • CUTR 2004
  • VIRX N/A
  • Fundamental
  • Price
  • CUTR $0.66
  • VIRX $0.22
  • Analyst Decision
  • CUTR Buy
  • VIRX Buy
  • Analyst Count
  • CUTR 4
  • VIRX 4
  • Target Price
  • CUTR $5.33
  • VIRX $5.50
  • AVG Volume (30 Days)
  • CUTR 146.2K
  • VIRX 146.3K
  • Earning Date
  • CUTR 11-07-2024
  • VIRX 11-07-2024
  • Dividend Yield
  • CUTR N/A
  • VIRX N/A
  • EPS Growth
  • CUTR N/A
  • VIRX N/A
  • EPS
  • CUTR N/A
  • VIRX N/A
  • Revenue
  • CUTR $169,188,000.00
  • VIRX N/A
  • Revenue This Year
  • CUTR N/A
  • VIRX N/A
  • Revenue Next Year
  • CUTR $5.13
  • VIRX N/A
  • P/E Ratio
  • CUTR N/A
  • VIRX N/A
  • Revenue Growth
  • CUTR N/A
  • VIRX N/A
  • 52 Week Low
  • CUTR $0.65
  • VIRX $0.20
  • 52 Week High
  • CUTR $4.97
  • VIRX $1.31
  • Technical
  • Relative Strength Index (RSI)
  • CUTR 39.79
  • VIRX 37.72
  • Support Level
  • CUTR $0.68
  • VIRX $0.20
  • Resistance Level
  • CUTR $0.79
  • VIRX $0.24
  • Average True Range (ATR)
  • CUTR 0.05
  • VIRX 0.01
  • MACD
  • CUTR -0.00
  • VIRX 0.00
  • Stochastic Oscillator
  • CUTR 2.86
  • VIRX 32.00

About CUTR Cutera Inc.

Cutera Inc is a medical device company. It specializes in the design, development, manufacture, marketing and servicing of laser and other energy based aesthetics systems for practitioners internationally. Its products include enlighten, excel HR, excel V, Xeo and Trusculpt 3D among others. The company markets and sells its products under the trademarks such as Cutera, Acutip, Coolglide, Enlighten, Excel HR, Excel V, Genesis plus, Pico-genesis, Titan, Trusculpt, and Xeo among others. It derives the majority of its revenue from the United States geographic segment.

About VIRX Viracta Therapeutics Inc.

Viracta Therapeutics Inc is a precision oncology company, focused on the development of new medicines targeting virus-associated malignancies. The company is conducting three clinical trials for its combination product candidate as a potential therapy for the treatment of relapsed/refractory Epstein-Barr virus-positive lymphoma. The product candidate of the company is a combination product candidate consisting of nanatinostat, a potent and selective small molecule inhibitor of class I histone deacetylases (HDAC), and valganciclovir, an FDA-approved anti-viral drug used to treat and prevent disease caused by a virus called cytomegalovirus (CMV) in people with organ transplants.

Share on Social Networks: